BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37278515)

  • 1. Aneurysms involving the coronary arteries in a neonate with neurofibromatosis 1.
    Corona-Rivera JR; Barrios-Prieto E; Rivera-Ramírez B; Sánchez-Uribe EH; Cortés-Pastrana RC; Aguilera CER; de Anda-Camacho RG; Peña-Padilla C; Bobadilla-Morales L; Corona-Rivera A
    Am J Med Genet A; 2023 Sep; 191(9):2422-2427. PubMed ID: 37278515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of neurofibromatosis 1 (NF1) lesions by body segment.
    Palmer C; Szudek J; Joe H; Riccardi VM; Friedman JM
    Am J Med Genet A; 2004 Mar; 125A(2):157-61. PubMed ID: 14981716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel NF1 mutation in a pediatric patient with renal artery aneurysm.
    Chillura I; Restivo GA; Callari S; Cibella S; D'Alessandro MM; Corrado C; Vallone M; Antona V; Corsello G
    Ital J Pediatr; 2022 Nov; 48(1):186. PubMed ID: 36411470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of multiple café-au-lait macules for neurofibromatosis 1 in Chinese children.
    Yao R; Wang L; Yu Y; Wang J; Shen Y
    J Dermatol; 2016 May; 43(5):537-42. PubMed ID: 26458495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
    Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
    J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
    Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
    J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder.
    Stewart DR; Brems H; Gomes AG; Ruppert SL; Callens T; Williams J; Claes K; Bober MB; Hachen R; Kaban LB; Li H; Lin A; McDonald M; Melancon S; Ortenberg J; Radtke HB; Samson I; Saul RA; Shen J; Siqveland E; Toler TL; van Maarle M; Wallace M; Williams M; Legius E; Messiaen L
    Genet Med; 2014 Jun; 16(6):448-59. PubMed ID: 24232412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
    Tong HX; Li M; Zhang Y; Zhu J; Lu WQ
    Genet Mol Res; 2012 Aug; 11(3):2972-8. PubMed ID: 22869071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple coronary artery aneurysms in a child with neurofibromatosis type 1.
    Ruggieri M; D'Arrigo G; Abbate M; Distefano A; Upadhyaya M
    Eur J Pediatr; 2000 Jul; 159(7):477-80. PubMed ID: 10923217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1.
    N Abdel-Aziz N; Y El-Kamah G; A Khairat R; R Mohamed H; Z Gad Y; El-Ghor AM; Amr KS
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1631. PubMed ID: 34080803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
    De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
    Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial café au lait spots: a variant of neurofibromatosis type 1.
    Abeliovich D; Gelman-Kohan Z; Silverstein S; Lerer I; Chemke J; Merin S; Zlotogora J
    J Med Genet; 1995 Dec; 32(12):985-6. PubMed ID: 8825931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple or familial café-au-lait spots is neurofibromatosis type 6: clarification of a diagnosis.
    Madson JG
    Dermatol Online J; 2012 May; 18(5):4. PubMed ID: 22630574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unroofed coronary sinus in a patient with neurofibromatosis type 1.
    Bender LP; Meyer MR; Rosa RF; Rosa RC; Trevisan P; Zen PR
    Rev Paul Pediatr; 2013 Dec; 31(4):546-9. PubMed ID: 24473962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of neurofibromatosis type 1 after rupture of aneurysm and consequent fatal hemothorax.
    Miyamoto K; Nakamura M; Suzuki K; Katsuki S; Kaki Y; Inoue G; Ohno T; Sasaki J; Dohi K; Hayashi M
    Am J Emerg Med; 2020 Jul; 38(7):1543.e3-1543.e5. PubMed ID: 32305158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdomyosarcoma as the first presentation in Neurofibromatosis Type 1: case series and review of the literature.
    Castle AMR; Empringham B; Pinto LM; Villani A; Kanwar N; Abbott LS; Sawyer SL
    Pediatr Hematol Oncol; 2023; 40(5):506-515. PubMed ID: 36625737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.